X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (53) 53
humans (47) 47
male (43) 43
aged (42) 42
middle aged (41) 41
prognosis (38) 38
oncology (36) 36
female (32) 32
vdp (32) 32
medical disciplines: 700 (31) 31
medisinske fag: 700 (31) 31
clinical medical disciplines: 750 (28) 28
klinisk medisinske fag: 750 (28) 28
oncology: 762 (28) 28
onkologi: 762 (28) 28
adult (26) 26
vdp::medical disciplines: 700::clinical medical disciplines: 750::oncology: 762 (26) 26
vdp::medisinske fag: 700::klinisk medisinske fag: 750::onkologi: 762 (26) 26
aged, 80 and over (25) 25
carcinoma, non-small-cell lung - pathology (25) 25
lung neoplasms - pathology (24) 24
neoplasm staging (21) 21
nsclc (20) 20
expression (19) 19
immunohistochemistry (19) 19
lung cancer (19) 19
tumors (18) 18
angiogenesis (17) 17
multidisciplinary sciences (17) 17
carcinoma, non-small-cell lung - mortality (16) 16
lung cancer, non-small cell (16) 16
lung neoplasms - mortality (16) 16
prostate cancer (16) 16
survival (16) 16
biomarkers, tumor - metabolism (15) 15
cancer (15) 15
medicine (15) 15
carcinoma, non-small-cell lung - metabolism (14) 14
lung neoplasms - metabolism (14) 14
pathology (14) 14
carcinoma (13) 13
metastasis (13) 13
research article (13) 13
science (13) 13
respiratory system (12) 12
retrospective studies (12) 12
multivariate analysis (11) 11
carcinoma, non-small-cell lung - immunology (10) 10
disease-free survival (10) 10
endothelial growth-factor (10) 10
hospitals (10) 10
mirna (10) 10
stroma (10) 10
stromal cells (10) 10
analysis (9) 9
cell survival (9) 9
lymphocytes, tumor-infiltrating - immunology (9) 9
non-small cell lung carcinoma (9) 9
patients (9) 9
prognostic impact (9) 9
prostate (9) 9
prostatic neoplasms - pathology (9) 9
tissue array analysis (9) 9
basale medisinske, odontologiske og veterinærmedisinske fag: 710 (8) 8
basic medical, dental and veterinary science disciplines: 710 (8) 8
biology (8) 8
carcinoma, non-small-cell lung - genetics (8) 8
gene expression (8) 8
gene expression regulation, neoplastic (8) 8
impact (8) 8
lung neoplasms - immunology (8) 8
medical prognosis (8) 8
progression (8) 8
prostatic neoplasms - metabolism (8) 8
stromal cells - pathology (8) 8
tumor (8) 8
article (7) 7
cancers and neoplasms (7) 7
carcinoma, non-small-cell lung - diagnosis (7) 7
carcinoma, squamous cell - metabolism (7) 7
hypoxia (7) 7
lung neoplasms - diagnosis (7) 7
lung neoplasms - genetics (7) 7
prostatectomy (7) 7
research (7) 7
survival analysis (7) 7
survival rate (7) 7
adenocarcinoma (6) 6
adenocarcinoma - metabolism (6) 6
biochemistry (6) 6
cancer therapies (6) 6
care and treatment (6) 6
cell biology (6) 6
cell line, tumor (6) 6
chemotherapy (6) 6
clinical medicine (6) 6
development and progression (6) 6
growth (6) 6
hematology, oncology and palliative medicine (6) 6
immune contexture (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Translational Medicine, ISSN 1479-5876, 01/2011, Volume 9, Issue 1, pp. 6 - 6
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2012, Volume 7, Issue 1, p. e29671
Background: Angiogenesis is regarded as a hallmark in cancer development, and anti-angiogenic treatment is presently used in non-small cell lung cancer (NSCLC)... 
PROGNOSTIC IMPACT | COEXPRESSION | POOR SURVIVAL | MULTIDISCIPLINARY SCIENCES | EXPRESSION PROFILES | STROMAL CELLS | HYPOXIA | HISTOLOGY | CARCINOMA | MICROARRAY DATA | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Reproducibility of Results | Carcinoma, Non-Small-Cell Lung - blood supply | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Transcriptome | Lung Neoplasms - pathology | Male | Polymerase Chain Reaction | Female | Neovascularization, Pathologic - genetics | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Cohort Studies | Lung Neoplasms - blood supply | MicroRNA | Genes | Development and progression | Lung cancer, Small cell | Fibroblast growth factors | Metastasis | Lung cancer, Non-small cell | Gene expression | Fibroblast growth factor | Identification methods | Lung cancer | Oncology | Biology | Genomes | Paraffin | Kinases | Cancer therapies | Metastases | Angiogenesis | User interface | Bioinformatics | Fibroblast growth factor 2 | Markers | MiRNA | Non-small cell lung carcinoma | Principal components analysis | Patients | Medicine | Pathology | Hospitals | DNA microarrays | Ribonucleic acids | Biological warfare | Correlation analysis | Deflation | Hypoxia | Clinical medicine | Cancer | Apoptosis | Tumors | Medisinsk genetikk: 714 | VDP | Basic medical, dental and veterinary science disciplines: 710 | Oncology: 762 | Klinisk medisinske fag: 750 | Onkologi: 762 | Medical genetics: 714 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Basale medisinske, odontologiske og veterinærmedisinske fag: 710
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181527
Introduction To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to... 
PROGNOSTIC IMPACT | MULTIDISCIPLINARY SCIENCES | HEPATOCYTE GROWTH-FACTOR | C-MET | PROTEIN EXPRESSION | IN-SITU HYBRIDIZATION | RESISTANCE | RECEPTOR | GENE COPY NUMBER | SCATTER-FACTOR | CLINICAL-SIGNIFICANCE | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Insulin-Like Growth Factor I - genetics | Female | Lung - metabolism | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - epidemiology | Gene Dosage | Proto-Oncogene Proteins c-met - genetics | Lung Neoplasms - epidemiology | Survival Analysis | Receptors, Somatomedin - genetics | Aged | Mutation | Chromosomes, Human, Pair 7 - genetics | Lung Neoplasms - diagnosis | Gene mutations | Genetic aspects | Research | Gene expression | Lung cancer, Non-small cell | Liver cells | Insulin-like growth factor 1 | Adenocarcinoma | Copy number | Insulin-like growth factor I | Lung cancer | Insulin-like growth factors | Paraffin | Males | Multivariate analysis | Kinases | Formaldehyde | Alterations | Cell growth | Insulin-like growth factor I receptors | MET protein | Chromosome 15 | Cell survival | Epidermal growth factor receptors | Tumor cells | Chromosome 7 | Non-small cell lung carcinoma | Patients | Survival | Silver | Tumors | Cancer | VDP | Klinisk medisinske fag: 750 | Onkologi: 762 | Oncology: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700
Journal Article
Human Pathology, ISSN 0046-8177, 09/2018, Volume 79, pp. 188 - 198
The presence of tumor-infiltrating lymphocytes (TILs) positively impacts the outcome of non–small cell lung cancer (NSCLC) patients. Most previous studies have... 
Prognosis | TILs | Tumor-infiltrating lymphocytes | NSCLC | Lung cancer | Immunoscore | REVISION | CLASSIFICATION | PATHOLOGY | DENSITY | TNM STAGE GROUPINGS | PROPOSALS | RECOMMENDATIONS | RECURRENCE | EDITION | Staining and Labeling - methods | Predictive Value of Tests | Adenocarcinoma of Lung - pathology | Lung Neoplasms - mortality | Stromal Cells - pathology | Carcinoma, Squamous Cell - pathology | Coloring Agents | Humans | Middle Aged | Carcinoma, Squamous Cell - surgery | Lung Neoplasms - pathology | Male | Pneumonectomy | Adenocarcinoma of Lung - mortality | Carcinoma, Squamous Cell - mortality | Time Factors | Hematoxylin | Female | Retrospective Studies | Adenocarcinoma of Lung - immunology | Carcinoma, Non-Small-Cell Lung - pathology | Reproducibility of Results | Carcinoma, Non-Small-Cell Lung - surgery | Risk Factors | Stromal Cells - immunology | Adenocarcinoma of Lung - surgery | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Disease-Free Survival | Lung Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - pathology | Lung Neoplasms - surgery | Aged | Neoplasm Staging | Observer Variation | Eosine Yellowish-(YS) | Lymphocytes, Tumor-Infiltrating - immunology | Medical research | Squamous cell carcinoma | Lymphocytes | Patient outcomes | Analysis | Medicine, Experimental | Lung cancer, Small cell | Lung cancer, Non-small cell | Tumors | Studies | Chemotherapy | Medical prognosis | Classification | Breast cancer | Patients
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 11/2017, Volume 66, Issue 11, pp. 1449 - 1461
The immune checkpoint receptor CTLA-4 plays a crucial part in negatively regulating T cell activation and maintaining self-tolerance. It is frequently... 
Immunology | Medicine & Public Health | Immunoscore | Non-small cell lung cancer | Oncology | Cancer Research | CTLA-4 | Immune checkpoints | Prognostic | APOPTOSIS | MARKER | PATHOLOGY | IMMUNOLOGY | DOCETAXEL | INFILTRATION | BIOMARKERS | GENE | ONCOLOGY | NIVOLUMAB | PROGRESSION | Multivariate Analysis | Adenocarcinoma - pathology | Lymph Nodes - pathology | Prognosis | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Tumor Microenvironment | Lung Neoplasms - pathology | Male | CTLA-4 Antigen - biosynthesis | Immunohistochemistry - statistics & numerical data | Adenocarcinoma - metabolism | Aged, 80 and over | Adult | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - metabolism | Proportional Hazards Models | Lymphatic Metastasis | Disease-Free Survival | Aged | Neoplasm Staging | Care and treatment | Squamous cell carcinoma | Analysis | Resveratrol | Lung cancer, Small cell | Metastasis | T cells | Lung cancer, Non-small cell | Lymphatic system | Cell survival | Epithelial cells | Lung cancer | Non-small cell lung carcinoma | Lymphocytes T | Self | Tissues | Patients | Immunological tolerance | Lymph nodes | Metastases | CTLA-4 protein | Cell activation | Immune checkpoint | Stromal cells | Microenvironments | Tumors | Cancer | Lymph | VDP | Klinisk medisinske fag: 750 | Onkologi: 762 | Oncology: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Original
Journal Article